21
Feb
22
Feb

Dublin

Presented by

IPHA IPHA
BPCI BPCI
NIBRT NIBRT

Event Sponsors

PWC PWC

Agency partners

Intertrade Ireland Intertrade Ireland

Day 2 Plenary session

08.00
Registration
08.30
Simon Harris, TD, Minister for Health
Opening Address
9.00
Session 3: Unlocking the collaborative potential of data and clinical research
- Richard L. Schilsky, MD, FACP, FASCO, Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO)
Improving the efficiency of clinical trials and the effectiveness of clinical care through data sharing

- Dr Muhammed Ali, Executive Director, Healthcare Solutions Strategy EMEAC Commercial Strategy & Operations, MSD International
Augmented learning in industry, the gift of artificial intelligence

Followed by panel discussion
10.10
Networking break
10.40
Session 4: Manufacturing for the future
- Prof Michael Zaworotko, Bernal Chair of Crystal Engineering & Science Foundation of Ireland Research Professor, University of Limerick, Ireland
Why crystals matter to the real world

- Graham Symcox, Managing Director, PharmaCentaur AG

- Brendan O’Callaghan, SVP & Global Head Biologics Platform, Sanofi

Followed by panel discussion
12.00
Networking lunch
13.00
Session 5: Adopting innovation; Delivering value
- Dr Karina Ehrig, Scientific Advisor, Gemeinsamer Bundesausschuss (Federal Joint Committee)
Assessing value to deliver patient benefits quickly – German and European perspectives

- Moheb Nasr, Ph.D.
Manufacturing Innovation: Regulatory Considerations

- Lynn Allen-Hoffmann, SVP Regenerative Medicine, Mallinckrodt Pharmaceuticals
StrataGraft: Discovery to Phase III Clinical Trial

- Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA).
IP Incentives – key to unlocking innovation

Followed by panel discussion
14.30
Matt Moran, Director, BioPharmaChem Ireland
Closing address
Close